Alan Kivitz, MD
Enriched profilePresident, Founder, and Medical Director · Altoona Arthritis & Osteoporosis Center
Alan Kivitz is President, Founder, and Medical Director at Altoona Arthritis & Osteoporosis Center. OpenAlex indexes 349 publications with 20,101 citations (h-index 75); ClinicalTrials.gov lists 22 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Rheumatology profiles in the findmyKOL directory.
Data verified 25 Aug 2026
Overview
Updated 27 Aug 2026
Alan J. Kivitz, MD, is President, Founder, and Medical Director at Altoona Arthritis & Osteoporosis Center / Altoona Center for Clinical Research (Duncansville, PA). The public record shows 349 publications with 20,101 citations (h-index 75), centered on Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments, Psoriasis: Treatment and Pathogenesis. It also documents an investigator role on 22 registered clinical trials, industry payments reported by 59 companies.
- Most recent indexed publication: 2026 · Rheumatology and therapy
- Top research focus: Rheumatoid Arthritis Research and Therapies
- 22 registered trials on ClinicalTrials.gov
- Open Payments reporting from 59 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 12 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 186.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 22 registered studies on ClinicalTrials.gov. The most recent:
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
Sponsor: Eli Lilly and Company
Industry payments
Updated 27 Aug 2026
59 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year2025217 payments$46,405openpaymentsdata.cms.gov ↗
- UCB, Inc.Program year202555 payments$23,391openpaymentsdata.cms.gov ↗
- Tonix Medicines, Inc.Program year20257 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
81.8%TNF inhibitor52.1%Certolizumab pegol76%Golimumab24%Enbrel Sureclick0%Humira(Cf) Pen0%Part D + Part B≥37 patientsInterleukin-6 Receptor Antagonist22.2%Tocilizumab100%Actemra0%Kevzara0%Part D + Part B<11 patientsMusculoskeletal
11.4%Other drugs affecting bone structure and mineralization7.7%Romosozumab-aqqg100%Evenity (2 Syringes)0%Part D + Part B<11 patientsRANK Ligand Inhibitor3.6%Denosumab99%Prolia1%Part D + Part B≥88 patientsDermatology
5.8%Corticosteroid5.8%Methylprednisolone acetate75%Triamcinolone acetonide16%Methylprednisolone sodium succinate9%Methylprednisolone1%Part D + Part B≥132 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- A Narrative Review of Secukinumab in Spondyloarthritis and Psoriatic Arthritis: Treating the Whole Patient.
Rheumatology and therapy
Review2026 - Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial.
Nature medicine
Clinical Trial2025 - Efficacy and Safety of Intravenous Secukinumab for the Treatment of Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase 3 Study.
Arthritis & rheumatology (Hoboken, N.J.)
Clinical Trial2025 - Real-world Effectiveness of Sarilumab in RA: Results from the Open-label, Prospective, Single-arm Observational PROFILE Study.
Rheumatology and therapy
Article2024
Most-cited works
by citation count (OpenAlex)- 01Denosumab in Postmenopausal Women with Low Bone Mineral Density1,215 citations2006
- 02
- 03
- 04
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- ResearchGate
researchgate.net/profile/Alan-Kivitz
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - LinkedIn
linkedin.com/in/alan-kivitz-md-macr-0a86355
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Other
rheum-live.com/view/alan-kivitz-md-phase-2b-data-tak-279-for-psoriatic-arthritis
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rheum-live.com ↗ - LinkedIn
LinkedIn profile: Alan Kivitz MD MACR, President, Altoona Arthritis & Osteoporosis Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - Doximity
Doximity profile: Dr. Alan Kivitz, MD – Duncansville, PA, Rheumatology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Certified Principal Investigator (CPI)
Association of Clinical Research Professionals, since 2004
2004verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acrpnet.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →altoonaarthritis.com ↗
- Board Certified
Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →altoonaarthritis.com ↗ - Board Certified
Rheumatology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →altoonaarthritis.com ↗ - Internal Medicine internship/residency
North Shore University Hospital and Memorial Sloan Kettering Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acrpnet.org ↗ - Rheumatology Fellowship
Albany Medical College
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acrpnet.org ↗ - Undergraduate
Rensselaer Polytechnic Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acrpnet.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acrpnet.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acrpnet.org ↗
- Practicing Rheumatologist
treating patients alongside three other rheumatology physicians and six advanced practice providers
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acrpnet.org ↗
Awards & honors
honors on the public record- ACRP 2025 Certification Milestone Achiever
recognized for 20+ consecutive years (since 2004) as a Certified Principal Investigator (CPI)
2004verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acrpnet.org ↗ - MACR
Master designation, American College of Rheumatology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →altoonaarthritis.com ↗
Secondary affiliations
appointments beyond the home institution- Member
Pennsylvania Medical Society
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →altoonaarthritis.com ↗ - Member
American Medical Association
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →altoonaarthritis.com ↗ - Member
International Society for Clinical Densitometry
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rheum-live.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →times-news.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University